1. Jung JW, Kim JY. Characteristics of a “rebound” in smoking after a tobacco price increase. Int J Tuberc Lung Dis 2020;24:390-5.
2. Korea Centers for Disease Control and Prevention. The 7th Korea National Health and Nutrition Examination Survey (KNHANES VII). Cheongju: Korea Centers for Disease Control and Prevention; 2019.
5. Ajzen I, Brown TC, Carvajal F. Explaining the discrepancy between intentions and actions: the case of hypothetical bias in contingent valuation. Pers Soc Psychol Bull 2004;30:1108-21.
7. Brown CJ, Cheng JM. Electronic cigarettes: product characterisation and design considerations. Tob Control 2014;23 Suppl 2:ii4-10.
9. Korea Centers for Disease Control and Prevention. The 11th Korea Youth Risk Behavior Web-based Survey. Cheongju: Korea Centers for Disease Control and Prevention; 2015.
10. Hori A, Tabuchi T, Kunugita N. Rapid increase in heated tobacco product (HTP) use from 2015 to 2019: from the Japan ‘Society and New Tobacco’ Internet Survey (JASTIS). Tob Control 2020 Jun 5 [Epub].
https://doi.org/10.1136/tobaccocontrol-2020-055652.
12. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, et al. Pulmonary illness related to E-cigarette use in Illinois and Wisconsin: final report. N Engl J Med 2020;382:903-16.
14. Department of Health Promotion; Ministry of Health and Welfare. The report for the analysis of suspectful, harmful components contained in domestically marketed closed system vaporizers. Sejong: Ministry of Health and Welfare; 2019.
15. Ministry of Economy and Finance. MOEF public report 132241438196990879. Sejong: Ministry of Economy and Finance; 2020.
16. Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004;23:464-76.
17. Statistics Korea. Statistics on the causes of death of Koreans in 2019. Daejeon: Statistics Korea; 2020.
18. Restrepo MI, Sibila O, Anzueto A. Pneumonia in patients with chronic obstructive pulmonary disease. Tuberc Respir Dis 2018;81:187-97.
19. Hong JY, Kang YA. Evaluation of the quality of care among hospitalized adult patients with community-acquired pneumonia in Korea. Tuberc Respir Dis 2018;81:175-86.
20. Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 1999;106:410-6.
24. Chang PY, Shiu MN, Yuan YT, Chang HC, Su PY, Lan TH. Comparative effectiveness of varenicline and nicotine replacement therapy for smoking cessation in older and younger smokers: a prospective cohort in Taiwan. Nicotine Tob Res 2019;21:149-55.
27. Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES trial. J Clin Psychopharmacol 2019;39:108-16.